Marketable Securities

9 Months Ended

Sep. 30, 2019

Investments, Debt and Equity Securities [Abstract]

Marketable Securities

Marketable Securities

Immunomedics considers all of its current investments to be available-for-sale. Marketable securities at September 30, 2019, consisted of the following (in thousands):

	Amortized Cost		Gross Unrealized Gain		Gross Unrealized (Loss)			Fair Value
U.S. Government Sponsored Agencies	$	4,941	$	—	$	(391	)	$	4,550

Maturities of debt securities classified as available-for-sale were as follows at September 30, 2019 (in thousands):

	Fair Value		Net Carrying Amount
Due after one year through five years	$	4,550	$	4,562

 

Marketable securities at December 31, 2018 consisted of the following (in thousands):

	Amortized Cost		Gross Unrealized Gain		Gross Unrealized (Loss)		Fair Value
U.S. Government Sponsored Agencies	$	4,941	$	—	$	—	$	4,941

 

Maturities of debt securities classified as available-for-sale were as follows at December 31, 2018 (in thousands):

	Fair Value		Net Carrying Amount
Due after one year through five years	$	4,941	$	4,954